PRO-XTEN
Live / Registered — Registered (as of 18 Feb 2025)
What this means for you
Registered since 18 Feb 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98228513
- Registration number
- 7692425
- Mark type
- Stylized text
- Filed
- 18 Oct 2023
- Published for opposition
- 31 Dec 2024
- Registered
- 18 Feb 2025
- Attorney of record
- Nicole E. Reifman
Goods and services
- Class 042 — Scientific and technological services: Scientific and technological services, namely, chemical, biological, medical, pharmaceutical and scientific research and development of vaccines and medicines; Scientific research in the nature of conducting of clinical trials for others; Scientific information services by providing scientific data in the field of oncology and immunology diseases.
Owner
- AMUNIX PHARMACEUTICALS, INC., South San Francisco, CA, US
- AMUNIX PHARMACEUTICALS, INC., South San Francisco, CA, US
- AMUNIX PHARMACEUTICALS, INC., South San Francisco, CA, US
Prosecution history
- 18 Feb 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 18 Feb 2025 — REGISTERED-PRINCIPAL REGISTER
- 31 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 Dec 2024 — PUBLISHED FOR OPPOSITION
- 25 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Dec 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Dec 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Dec 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 Dec 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 05 Sept 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 05 Sept 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 05 Jun 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 05 Jun 2024 — NON-FINAL ACTION E-MAILED
- 05 Jun 2024 — NON-FINAL ACTION WRITTEN
- 04 Jun 2024 — ASSIGNED TO EXAMINER